Good effort mmn but the trial requires 150 patients 98 / 1.9 = 51.57 months. And that's being generous.
You're talking about 4 and a half years if everything goes well which doesn't seem likely considering enrolment fell off the cliff right after summer as it does every year. Over the course of a year the average seems to gravitate towards its historical 1.2 per month. Also, weren't there supposed to be 4 more sites initiated by end of Q1 according to the last few press releases. Is there even 1 site initiated? I don't see it on fda.gov.. I do however see 3 withdrawn.
Is that $40 million dollars more in dilution?